Horizon Therapeutics Public Limited Company
HZNP
|
$116.3
0.03%
29M
|
Health Technology
(0.0% 1d) (0.0% 1m) (4.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (383.01% volume)
Earnings Calendar: 2023-11-01
Market Cap: $ 26,632,068,258
http://www.horizontherapeutics.com
Sec Filling | Patents | 1200 employees
Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.
add to watch list Paper trade email alert is off
Press-releases
Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in Humans
Published: 2024-03-05 (Crawled : 13:00) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: -3.69%
H: 4.0%
C: -0.58%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.17%
H: 0.0%
C: 0.0%
tnx-1500 pharmaceuticals preclinical
Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy Volunteers
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
TNXP | $0.1549 -2.82% -2.91% 1.4M
|
Health Technology
|
| O: 3.26%
H: 2.37%
C: -1.53%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
tnx-1500 pharmaceuticals trial
Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
LRMR | $6.39 -9.36% -10.33% 510K
|
Health Technology
|
| O: 0.42%
H: 16.25%
C: 6.67%
therapeutics financial results
Larimar Therapeutics Appoints Dr. Jeffery W. Sherman to its Board of Directors
Published: 2023-10-03 (Crawled : 20:00) - globenewswire.com
TAK | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -2.07%
H: 0.19%
C: -0.07%
LRMR | $6.39 -9.36% -10.33% 510K
|
Health Technology
|
| O: -1.27%
H: 0.0%
C: -2.42%
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.0%
H: 0.03%
C: 0.02%
therapeutics
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023
Published: 2023-10-02 (Crawled : 14:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.1%
H: 0.13%
C: 0.11%
uplizna therapeutics
New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes
Published: 2023-09-29 (Crawled : 23:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: -0.05%
tepezza disease treatment thyroid eye
Q32 Bio and Horizon Therapeutics plc Announce Dosing of First Patient in Phase 2 Trial of Bempikibart (formerly ADX-914) for Severe Alopecia Areata
Published: 2023-09-13 (Crawled : 13:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.23%
H: 0.28%
C: 0.14%
adx-914 trial therapeutics
AMGEN AND HORIZON THERAPEUTICS PLC RESOLVE FTC LAWSUIT, CLEARING PATH TO CLOSE ACQUISITION
Published: 2023-09-01 (Crawled : 13:30) - prnewswire.com
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 2.63%
H: 0.0%
C: -0.35%
BGNE S | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 0.36%
H: 2.44%
C: 0.3%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.91%
H: 0.14%
C: -0.76%
resolve acquisition therapeutics
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
Published: 2023-08-23 (Crawled : 14:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: -0.2%
H: 1.37%
C: 1.01%
rare disease therapeutics
Horizon Therapeutics plc to Release Second-Quarter 2023 Financial Results on Aug. 8, 2023
Published: 2023-07-17 (Crawled : 12:20) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 0.25%
H: 0.32%
C: -0.19%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.25%
H: 0.76%
C: 0.43%
therapeutics financial results
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
SNDA P 3000 | $29.61 3.35% 0.0% 30K
|
n/a
|
22:00
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
FAST P 3350 | $67.5 -1.43% -1.45% 3.6M
|
Distribution Services
|
20:00
QCRH | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
RVP P 15363 | $1.05 0.96% 0.0% 120K
|
Health Technology
|
18:00
VUZI | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
TPL P 3 | $582.4 -0.44% 0.0% 63K
|
Miscellaneous
|
15:00
RELL | $10.15 2.94% 2.86% 94K
|
Electronic Technology
|
13:30
IZEA | $2.65 4.74% 4.53% 31K
|
Technology Services
|
00:00
RKT P 383 | $11.53 1.32% 0.0% 1.6M
|
Finance
|
22:30
CTRN P 18090 | $22.28 -0.4% -0.4% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.8 0.36% -0.36% 54K
|
Energy Minerals
|
21:00
NEOG P 10000 | $11.94 -1.65% -1.68% 2.9M
|
Health Technology
|
16:30
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10